Mustafa KIRÇA, Akın YEŞİLKAYA

Losartan inhibits EGFR transactivation in vascular smooth muscle cells

Turkish Journal of Medical Sciences

2018-Cilt: 48 - Sayı: 6

1364-1371

Angiotensin II, EGF receptor, losartan, transactivation, extracellular regulated kinase, vascular smooth muscle, cardiovascular disease

93 94